Berkshire Hathaway Acquires 26 Billion Stake in Delta Air Lines Signaling Shift in Airline Sector Bet Mirabito Expands Footprint with Acquisition of 9 Quicklees Convenience Stores Prediction Market Signals Potential US Government Stakes in IonQ Micron and Anduril Panchamrutha Industries Unveils Fortified Rice with Essential Vitamins and Minerals in Bengaluru Trump Tariff Impact Global Economic Tracking and Market Implications Indian Markets Rally on Oil Price Decline and USIran Peace Optimism EC Q4 2025 Earnings EPS Misses Estimates Amid Mixed Operational Performance PSX Q1 2026 Earnings Strong Earnings Surprise Driven by Improved Refining Margins MODD Q3 2025 Earnings EPS Misses Expectations Stock Gains 89 OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance AMX Q1 2026 Earnings EPS Surpasses Expectations Amid Currency and Competition Challenges CDP Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Modest Stock Decline Yorkville Acquisition Corp Warrant MCGAW Edges Higher Key Levels and Speculative Dynamics Voya Global Advantage Fund IGA Edges Higher at 988 Testing Support and Resistance Levels NMP Acquisition Corp Right NMPAR Sees Sharp 1154 Spike Key Levels Under Scrutiny Neuphoria Therapeutics NEUP Slips Amid Sector Headwinds Key Support Levels in Focus Tivic Health Systems TIVC Holds Steady at 140 as Key Support and Resistance Levels Define Range Hong Kong Fire Survivors Race Against Government Buyout Deadline PAR Technology Q1 2026 Earnings Strong EPS Surprise Highlights Operational Efficiency NXP Semiconductors Edges Higher Amid Steady Demand in Semiconductor Sector LCI Industries Q1 2026 Earnings EPS Surprises by 157 as Shares Rise DMLP Q4 2024 Earnings EPS of 024 Reported Amid Stock Decline RF Q1 2026 Earnings Slight EPS Beat Amidst Challenging Interest Rate Environment PASG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand Kestrel Group Ltd Q3 2024 Earnings Reported Loss of 016 Per Share as Stock Edges Higher Dyne Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Advances